摘要
目的:探讨双歧杆菌三联活菌肠溶胶囊治疗非酒精性脂肪性肝病(NAFLD)患者的效果及对血清一氧化氮(NO)、内毒素、视黄醇结合蛋白4(RBP4)的影响。方法:选取2014年1月至2016年5月在我院治疗的NAFLD患者180例,采用SPSS16.0软件生成随机数字后分为研究组、对照组各90例,两组均采用常规保肝治疗,研究组加用双歧杆菌三联活菌肠溶胶囊,疗程12周。结果:治疗前,研究组的ALT、AST、GGT、TG、TC、IL-6、TNF-α、hs-CRP、NO、内毒素、RBP4水平与对照组差异无统计学意义(P>0.05);治疗后,研究组的ALT、AST、GGT、TG、TC、IL-6、TNF-α、hs-CRP、NO、内毒素、RBP4水平均低于对照组(P<0.05);研究组的治疗总有效率90.00%高于对照组的77.78%(P<0.05)。结论:双歧杆菌三联活菌肠溶胶囊治疗NAFLD患者具有减轻炎症反应、降低血清NO、内毒素、RBP4水平的作用,同时具有较好的保肝护肝功能。
Objective:To investigate the effect of Bifidobacterium triple live bacteria enteric-coated capsules on the treatment of NAFLD patients and the effect on serum NO,endotoxin and RBP4.Methods:180 patients with NAFLD treated in our hospital from January 2014 to May 2016 were selected,Using SPSS16.0 software to generate random numbers into study group,control group,90 cases,both groups were treated with conventional liver protection,the study group with bifidobacterium triple live Enteric-coated capsules,treatment for 12 weeks.Results:The levels of ALT,AST,GGT,TG,TC,IL-6,TNF-α,hs-CRP,NO,endotoxin and RBP4 in the study group were not significantly different from those in the control group before treatment(P>0.05).After treatment,the levels of ALT,AST,GGT,TG,TC,IL-6,TNF-a,hs-CRP,NO,endotoxin and RBP4 in the study group were all lower than those of the control group(P<0.05).The total effective rate of treatment in the study group was 90%higher than that of the control group 77.78%(P<0.05).Conclusion:Bifid Triple Viable Capsules Dissolving at Intestines treatment can reduce inflammation,reduce serum NO,endotoxin and RBP4 levels in patients with NAFLD,and it has good hepatoprotective function.
作者
李文刚
吴冬寒
符亮
吴武平
LI Wen-gang;WU Dong-han;FU Liang;WU Wu-ping(Department of digestive,Sanya people's Hospital,Sanya 572000,China)
出处
《东南大学学报（医学版）》
CAS
2018年第1期96-100,共5页
Journal of Southeast University(Medical Science Edition)
基金
三亚市医疗卫生科技创新项目(2014YW11)
关键词
双歧杆菌三联活菌肠溶胶囊
非酒精性脂肪肝
一氧化氮
内毒素
视黄醇结合蛋白4
bifid triple viable capsules dissolving at intestines
nonalcoholic fatty liver
nitric oxide
endotoxin
retinol binding protein 4
